Chargement en cours...
Do we still need breast cancer screening in the era of targeted therapies and precision medicine?
Breast cancer (BC) is the most common female cancer and the second cause of death among women worldwide. The 5-year relative survival rate recently improved up to 90% due to increased population coverage and women’s attendance to organised mammography screening as well as to advances in therapies, e...
Enregistré dans:
| Publié dans: | Insights Imaging |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Berlin Heidelberg
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7519022/ https://ncbi.nlm.nih.gov/pubmed/32975658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13244-020-00905-3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|